{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T11:40:14Z","timestamp":1788090014050,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.lrr.2026.100561","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T16:31:03Z","timestamp":1768235463000},"page":"100561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Imatinib-induced rhabdomyolysis: A case report"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9143-436X","authenticated-orcid":false,"given":"Jordan","family":"Rubenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Vankawala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Caplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph G.","family":"Jurcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lrr.2026.100561_bib0001","first-page":"935","article-title":"Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia","volume":"8","author":"Cohen","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lrr.2026.100561_bib0002","series-title":"Gleevec [prescribing information]","year":"2008"},{"issue":"2","key":"10.1016\/j.lrr.2026.100561_bib0003","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3324\/haematol.11680","article-title":"Alterations in creatine kinase, phosphate and lipid values in patients with chronic myeloid leukemia during treatment with imatinib","volume":"93","author":"Franceschino","year":"2008","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.lrr.2026.100561_bib0004","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.leukres.2009.11.002","article-title":"Elevations of creatine kinase in patients treated with imatinib mesylate (Gleevec\u2122)","volume":"34","author":"Gordon","year":"2010","journal-title":"Leuk Res."},{"key":"10.1016\/j.lrr.2026.100561_bib0005","unstructured":"National Center for Biotechnology Information. StatPearls: Rhabdomyolysis. Updated August 2023. Accessed July 18, 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448168\/."},{"key":"10.1016\/j.lrr.2026.100561_bib0006","unstructured":"National Center for Biotechnology Information. StatPearls: Creatine Kinase. Updated July 2023. Accessed July 18, 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551676\/."},{"issue":"4","key":"10.1016\/j.lrr.2026.100561_bib0007","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/bdrc.10030","article-title":"Biology of platelet-derived growth factors in development","volume":"69","author":"Betsholtz","year":"2003","journal-title":"Birth Defects Res. C Embryo Today"},{"issue":"1","key":"10.1016\/j.lrr.2026.100561_bib0008","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.1414","article-title":"Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study","volume":"201","author":"Zhao","year":"2003","journal-title":"J. Pathol."},{"issue":"8","key":"10.1016\/j.lrr.2026.100561_bib0009","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nm1446","article-title":"Cardiotoxicity of the cancer therapeutic agent imatinib mesylate","volume":"12","author":"Kerkel\u00e4","year":"2006","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.lrr.2026.100561_bib0010","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1177\/10781552231168563","article-title":"Inclusion body myositis triggered with long-term imatinib use","volume":"30","author":"Deniz","year":"2024","journal-title":"J. Oncol. Pharm. Pract."}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048926000014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048926000014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:10:51Z","timestamp":1785481851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048926000014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":10,"alternative-id":["S2213048926000014"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2026.100561","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imatinib-induced rhabdomyolysis: A case report","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2026.100561","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100561"}}